Clinical Trials in Salt Lake City

Showing 3561-3580 of 14,325 trials

Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer

NCT04742361

This study evaluates the diagnostic performance and safety of \[18F\]PSMA-1007 PET/CT imaging in patients with suspected recurrence of prostate cancer after previous definitive treatment.

Prostate CancerProstate Cancer Recurrent

ABX advanced biochemical compounds GmbH136 participantsStarted Aug 2021

Rochester, Minnesota, United States • Houston, Texas, United States • Houston, Texas, United States +3 more locations

COMPLETEDPhase 1< 1 mile

Pharmacodynamic Evaluation of Intranasal Nalmefene

NCT04828005

This study is to determine the pharmacodynamics (the effects of the drug and mechanisms of their action within the body) of Nalmefene when given intranasally (IN; into the nose) compared to intranasal naloxone when given to healthy volunteers under steady state opioid agonism.

Pharmacodynamic

Opiant Pharmaceuticals Inc84 participantsStarted Mar 2021

Salt Lake City, Utah, United States

TERMINATEDPhase 3< 1 mile

Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)

NCT05251909

This is a 3-part study. Part A is randomized, double-blinded, placebo-controlled and includes patients with eosinophilic gastritis and/or duodenal-only disease. After completing Part A, participants can continue to Part C - open-label benralizumab treatment period. Following the decision to close enrollment, patients in both Part A and Part C will be given the option to proceed to 6-months of open-label benralizumab treatment in Part D.

Eosinophilic GastritisEosinophilic Gastroenteritis

AstraZeneca12 participantsStarted Jan 2022

Chicago, Illinois, United States • Boston, Massachusetts, United States • Rochester, Minnesota, United States +17 more locations

Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer

Pharmacodynamic Evaluation of Intranasal Nalmefene

Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)

Find Trials by Condition in Salt Lake City

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

ALTO-100 in Bipolar Disorder With Depression (BD-D)

Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations

A Study to Compare Nighttime Aligners to Daytime Aligners

Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients

Ceramic-on-Ceramic (COC) 36mm Acetabular Bearing Insert Post Approval Study-New Subjects (COC36mmPAS)

Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer

A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis

MMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM

Long Term Follow Up for CTSN Mitral Valve Repair Studies

SYMPHONY-PE Study for Treatment of Pulmonary Embolism

A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD)

Performance Evaluation of the AMIA APD Solution Generation System in Patients End Stage Renal Disease (ESRD)

Technology and Family Thriving Study

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions